1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Circulating Tumor Cell (CTC) Diagnostics Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Circulating Tumor Cell (CTC) Diagnostics Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1
- 5.1.2 Rising cancer prevalence worldwide
- 5.1.3 Increased demand for non-invasive diagnostics
- 5.1.4 Advancements in CTC detection technologies
5.2 Market Opportunities
- 5.2.1
- 5.2.2 Expansion in liquid biopsy applications
- 5.2.3 Development of AI-driven diagnostics
- 5.2.4 Growth in personalized cancer treatments
5.3 Future Trends
- 5.3.1
- 5.3.2 Use of microfluidics in CTC isolation
- 5.3.3 Increased focus on predictive analytics
- 5.3.4 Integration with next-generation sequencing
5.4 Impact of Drivers and Restraints
6. North America Circulating Tumor Cell (CTC) Diagnostics Market Regional Analysis
6.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Overview
6.2 North America Circulating Tumor Cell (CTC) Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 North America Circulating Tumor Cell (CTC) Diagnostics Market Forecast Analysis
7. North America Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by Technology
7.1 CTC Detection and Enrichment Method
- 7.1.1 Overview
- 7.1.2 CTC Detection and Enrichment Method: North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.2 CTC Direct Detection Method
- 7.2.1 Overview
- 7.2.2 CTC Direct Detection Method: North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
7.3 CTC Analysis
- 7.3.1 Overview
- 7.3.2 CTC Analysis: North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by Application
8.1 Clinical/Liquid Biopsy
- 8.1.1 Overview
- 8.1.2 Clinical/Liquid Biopsy: North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Research
- 8.2.1 Overview
- 8.2.2 Research: North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Circulating Tumor Cell (CTC) Diagnostics Market Analysis – by End-User
9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Research: North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Research and Academic Institutes
- 9.2.1 Overview
- 9.2.2 Research: North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Diagnostic Centers
- 9.3.1 Overview
- 9.3.2 Research: North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. North America Circulating Tumor Cell (CTC) Diagnostics Market – North America Analysis
10.1 North America
- 10.1.1 North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.1.1.1 North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 US: North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
- 10.1.1.1.2 US: North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
- 10.1.1.1.3 US: North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
- 10.1.1.2 Canada:
North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Canada: North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
- 10.1.1.2.2 Canada: North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
- 10.1.1.2.3 Canada: North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
- 10.1.1.3 Mexico :
North America Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 Mexico : North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Technology
- 10.1.1.3.2 Mexico : North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by Application
- 10.1.1.3.3 Mexico : North America Circulating Tumor Cell (CTC) Diagnostics Market Breakdown, by End-User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Circulating Tumor Cell (CTC) Diagnostics Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 STEMCELL Technologies Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 QIAGEN
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Precision Medicine Group, LLC
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 EPIC LIFESCIENCES
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 SCREENCELL
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 IKONISYS, INC
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 IVDiagnostics
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 FLUXION BIOSCIENCES
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
Get Free Sample For North America Circulating Tumor Cell (CTC) Diagnostics Market
